Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: Up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-γ production

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2848-2855

  Shustov, Andrei ^a   Nguyen, Phuong ^a   Finkelman, Fred ^b   Elkon, Keith B ^c   Via, Charles S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; PERFORIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HELPER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD95; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT VS HOST DISEASE; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PORE FORMING CYTOTOXIC PROTEINS; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TISSUE DONORS; UP-REGULATION;

EID: 0032530294     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
2. Drappa, J., A. K. Vaishnaw, K. E. Sullivan, J. Chu, and K. B. Elkon. 1996. Fas gene mutations in Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autotimmunity. N. Engl. J. Med. 335:1643.
3. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 57:319.
4. Ashany, D., X. Song, E. Lacy, J. Nikolik-Zugic, S. M. Friedman, and K. B. Elkon. 1995. Lymphocytes delete activated macrophages through the Fas/ APO-1 pathway. Proc. Natl. Acad. Sci. USA 92:11225.
5. Takayama, H., H. Kojima, and N. Shinohara. 1995. Cytotoxic T lymphocytes: the newly identified Fas (CD95)-mediated killing mechanism and a novel aspect of their biological functions. Adv. Immunol. 60:289.
6. + T cells. Immunol. Rev. 146:223.
7. Elkon, K. B., and A. Marshak-Rothstein. 1996. B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr. Opin. Immunol. 8:852.
8. Foote, L. C., R. G. Howard, A. Marshak-Rothstein, and T. L. Rothstein. 1996. IL-4 induces Fas-resistance in B cells. J. Immunol. 157:2749.
9. Singh, J. N., E. Sabbadini, and A. H. Sehon. 1972. Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells. J. Exp. Med. 136:39.
10. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease. J. Immunol. 139:1840.
11. Rozendaal, L., S. T. Pals, M. Schilham, C. J. M. Melief, and E. Gleichmann. 1989. Allosuppression of B cells in vitro by graft-versus-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Eur. J. Immunol. 19:1669.
12. Gleichmann, E., S. T. Pals, A. G. Rolink, T. Radaszkiewicz, and H. Gleichmann. 1984. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5:324.
13. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse T helper clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally non-specific bioassays and monoclonal antibodies. J. Exp. Med. 166:1229.
14. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. MacDonald. 1985. Expression of interleukin -2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
15. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
16. + T helper cell function in association with autoimmunity. J. Exp. Med. 168:2165.
17. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
18. Svetic, A., F. D. Finkelman, C. Jian, C. W. Dieffenbach, D. E. Scott. K. F. McCarthy, A. D. Steinberg, and W. C. Gause. 1991. Cytokine gene expression following in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391.
19. Unkeless, J. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
20. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94:3914.
21. Via, C. S. 1991. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease. J. Immunol. 146:2603.
22. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perform- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156:3678.
23. + T cells. J. Immunol. 155:2396.
24. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
25. Williamson, E., P. Garside, J. A. Bradley, and A. M. Mowat. 1996. IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157:689.
26. Via, C. S., P. H. Nguyen, A. Shustov, J. Drappa, and K. B. Elkon. 1996. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157:5387.
27. Braun, M. Y., B. Lowin, F. Lars, H. Acha-Oreba, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
28. Baker, M. B., N. H. Altman, E. R. Podack, and R. B. Levy. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645.
29. Hahn, S., R. Gehri, and P. Erb. 1995. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:57.
30. Dao, T., K. Ohashi, T. Kayano, M. Kurimoto, and H. Okamura. 1996. Interferon-γ inducing factor, a novel cytokine, enhances Fas ligand mediated cytotoxicity in murine T helper 1 cells. Cell. Immunol 173:230.
31. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
32. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing. J. Exp. Med. 186:2045.
33. Kosmatopoulos, K., D. S. Algara, and S. Orbach-Arbouys. 1987. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft-versus-host reaction. J. Immunol. 138:1038.
34. Mountz, J. D., J. Wu, J. Cheng, and T. Zhou. 1994. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum. 37:1415.
35. Reap, E. A., D. Leslie, M. Abrahams, R. A. Eisenberg, and P. L. Cohen. 1995. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154:936.
36. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
37. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell (Th1) and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837.
38. Via, C. S., V. Rus, M. K. Gately, and F. D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153:4040.